Overcoming One Phobia Might Ease Other Fears, Study Finds
Medically reviewed by Drugs.com.
By Dennis Thompson HealthDay Reporter
FRIDAY, Jan. 12, 2024 -- Imagine easing a fear of heights by getting over a phobia of spiders.
That might sound odd, but it works, researchers report.
Folks who use exposure therapy to overcome one phobia can find themselves less afraid of other things, according to the results of a study published recently in the journal Translational Psychiatry.
It’s very often the case that people prone to phobias often develop more than one, said lead researcher Iris Kodzaga, a doctoral student with Ruhr University Bochum’s Department of Behavioral and Clinical Neuroscience.
“Anxiety rarely comes alone,” Kodzaga said in a university news release. “Patients who suffer from one fear often subsequently develop another.”
Exposure therapy has proven to be the most effective treatment against phobias, researchers said. By confronting a fear-inducing situation under the supervision of a therapist, patients learn to overcome their fear.
However, it has been long assumed that a person with multiple fears would require multiple rounds of exposure therapy, with each round targeting a different phobia, Kodzaga noted.
To challenge that assumption, researchers performed exposure therapy treating a fear of spiders on 50 people who also had a fear of heights.
Prior to the therapy, participants answered questionnaires and performed tasks to quantify their phobias. For example, researchers noted how close the subjects dared approach a spider, and how far they could climb a high church tower.
People who underwent exposure therapy for spiders wound up experiencing an average 15% reduction in their fear of heights, results show.
It’s not clear exactly why the effect of exposure therapy transferred from one fear to the other, Kodzaga said.
It might be because people gain more confidence as a result of conquering one powerful phobia, she noted.
“But perhaps there is also a common denominator between fear of spiders and fear of heights that’s not obvious,” Kodzaga said. “We’ll need to conduct follow-up studies to find out more.”
Nonetheless, this outcome “opens up new perspectives for the efficient treatment of phobias,” Kodzaga added.
“It could mean that we can rethink therapeutic approaches and possibly develop more universal methods [of treatment],” she added.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-01-12 22:15
Read more
- Nipocalimab is the First and Only Investigational Therapy Granted U.S. FDA Breakthrough Therapy Designation for the Treatment of Adults Living with Moderate-to-Severe Sjögren’s Disease
- Global TB Cases Hit Record High, TB Becomes Top Infectious Disease Killer
- How Would Billing for Secure Messages Impact Patients, Physicians?
- Ozempic, Wegovy Could Help Ease Knee Arthritis Pain
- Ionis Announces FDA Acceptance of New Drug Application for Donidalorsen for Prophylactic Treatment of HAE
- LENZ Therapeutics Announces FDA Acceptance of New Drug Application for LNZ100 for the Treatment of Presbyopia
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions